Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry describes a **pseudogene** related to the Polyadenylate-binding protein 1, nuclear (**PABPN1**). Pseudogenes are non-functional segments of DNA that resemble functional genes but do not encode functional proteins. As such, this pseudogene does not produce an active protein product and is not considered a therapeutic target, such as a receptor, enzyme, or transporter. No biological function, disease relevance, interacting drugs, or biomarker roles are attributed to this entry. The functional **PABPN1** gene is involved in mRNA processing, specifically polyadenylation, RNA export from the nucleus, and regulation of mRNA turnover[1][3][5]. However, this pseudogene (ENSG00000233710/LOC100288853) does not encode the functional protein and is generally of interest only in genomic studies or as a marker of gene evolution. - There is something incorrect with this entry as a therapeutic target: it is **not a protein-coding gene, nor a functional molecular target** in drug development or biology. - If you intended to refer to the functional protein, the correct entry is "Polyadenylate-binding protein 1, nuclear" (PABPN1)[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polyadenylate-binding protein 1, nuclear pseudogene.